Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
Tuberculosis, Pulmonary
Interventions
DRUG

Atorvastatin 40mg

12 weeks of 40 mg atorvastatin therapy per os

DRUG

Placebo oral tablet

Identical placebo

Trial Locations (1)

7925

RECRUITING

General Medicine & Global Health, Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Observatory

All Listed Sponsors
collaborator

University of Zurich

OTHER

collaborator

University of Namibia

OTHER

collaborator

University of Bern

OTHER

collaborator

University of Stellenbosch

OTHER

lead

University of Cape Town

OTHER